Clinical Trial Update: Combination Therapy of Omalizumab and Allergen Immunotherapy for Moderate to Severe Asthma

View source ↗

Summary

This document reports a clinical trial evaluating the combination of omalizumab and allergen immunotherapy for allergic asthma, with the study currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Allergen Immunotherapy
• Omalizumab (Omalizumab)

Snippet

Sponsor: Qianfoshan Hospital | Conditions: Allergic Asthma | Status: ACTIVE_NOT_RECRUITING